Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Gennaro Daniele; Laura Arenare; Giovanni Scambia; Carmela Pisano; Roberto Sorio; Enrico Breda; Sabino De Placido; Antonella Savarese; Maria Gabriella Ferrandina; Francesco Raspagliesi; Pierluigi Benedetti Panici; Antonella Ferro; Anita Rimanti; Gennaro Cormio; Domenica Lorusso; Sabrina Chiara Cecere; Simona Scalone; Valentina Angela Marsico; Cinzia Cardalesi; Francesco Cognetti; Vanda Salutari; Laura Attademo; Lorenzo Guizzaro; Clorinda Schettino; Maria Carmela Piccirillo; Francesco Perrone; Ciro Gallo; Sandro Pignata

doi:10.1016/j.ygyno.2019.04.012

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Gennaro Daniele
, Laura Arenare
, Giovanni Scambia
, Carmela Pisano
, Roberto Sorio
, Enrico Breda
, Sabino De Placido
, Antonella Savarese
, Maria Gabriella Ferrandina
, Francesco Raspagliesi
, Pierluigi Benedetti Panici
, Antonella Ferro
, Anita Rimanti
, Gennaro Cormio
, Domenica Lorusso
, Sabrina Chiara Cecere
, Simona Scalone
, Valentina Angela Marsico
, Cinzia Cardalesi
, Francesco Cognetti

Vanda Salutari, Laura Attademo, Lorenzo Guizzaro, Clorinda Schettino, Maria Carmela Piccirillo, Francesco Perrone, Ciro Gallo, Sandro Pignata

Risultato della ricerca: Contributo in rivista › Articolo

3 Citazioni (Scopus)

Abstract

Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.

Lingua originale	Inglese
pagine (da-a)	83-88
Rivista	Gynecologic Oncology
Volume	154
DOI	https://doi.org/10.1016/j.ygyno.2019.04.012
Stato di pubblicazione	Pubblicato - 2019

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Chemotherapy-induced neutropenia
Cytotoxic dosing methods
Meta-analysis
Obstetrics and Gynecology
Oncology
Ovarian cancer
Prognostic factors
Retrospective-prospective design

Accesso al documento

10.1016/j.ygyno.2019.04.012

Altri file e collegamenti

Cita questo

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, M. G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., ... Pignata, S. (2019). Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials. Gynecologic Oncology, 154, 83-88. https://doi.org/10.1016/j.ygyno.2019.04.012

@article{f24381881ff14976ba05aeb02676a24c,

title = "Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials",

abstract = "Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.",

keywords = "Chemotherapy-induced neutropenia, Cytotoxic dosing methods, Meta-analysis, Obstetrics and Gynecology, Oncology, Ovarian cancer, Prognostic factors, Retrospective-prospective design, Chemotherapy-induced neutropenia, Cytotoxic dosing methods, Meta-analysis, Obstetrics and Gynecology, Oncology, Ovarian cancer, Prognostic factors, Retrospective-prospective design",

author = "Gennaro Daniele and Laura Arenare and Giovanni Scambia and Carmela Pisano and Roberto Sorio and Enrico Breda and \{De Placido\}, Sabino and Antonella Savarese and Ferrandina, \{Maria Gabriella\} and Francesco Raspagliesi and Panici, \{Pierluigi Benedetti\} and Antonella Ferro and Anita Rimanti and Gennaro Cormio and Domenica Lorusso and Cecere, \{Sabrina Chiara\} and Simona Scalone and Marsico, \{Valentina Angela\} and Cinzia Cardalesi and Francesco Cognetti and Vanda Salutari and Laura Attademo and Lorenzo Guizzaro and Clorinda Schettino and Piccirillo, \{Maria Carmela\} and Francesco Perrone and Ciro Gallo and Sandro Pignata",

year = "2019",

doi = "10.1016/j.ygyno.2019.04.012",

language = "English",

volume = "154",

pages = "83--88",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

}

Daniele, G, Arenare, L, Scambia, G, Pisano, C, Sorio, R, Breda, E, De Placido, S, Savarese, A, Ferrandina, MG, Raspagliesi, F, Panici, PB, Ferro, A, Rimanti, A, Cormio, G, Lorusso, D, Cecere, SC, Scalone, S, Marsico, VA, Cardalesi, C, Cognetti, F, Salutari, V, Attademo, L, Guizzaro, L, Schettino, C, Piccirillo, MC, Perrone, F, Gallo, C & Pignata, S 2019, 'Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials', Gynecologic Oncology, vol. 154, pagg. 83-88. https://doi.org/10.1016/j.ygyno.2019.04.012

TY - JOUR

T1 - Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

AU - Daniele, Gennaro

AU - Arenare, Laura

AU - Scambia, Giovanni

AU - Pisano, Carmela

AU - Sorio, Roberto

AU - Breda, Enrico

AU - De Placido, Sabino

AU - Savarese, Antonella

AU - Ferrandina, Maria Gabriella

AU - Raspagliesi, Francesco

AU - Panici, Pierluigi Benedetti

AU - Ferro, Antonella

AU - Rimanti, Anita

AU - Cormio, Gennaro

AU - Lorusso, Domenica

AU - Cecere, Sabrina Chiara

AU - Scalone, Simona

AU - Marsico, Valentina Angela

AU - Cardalesi, Cinzia

AU - Cognetti, Francesco

AU - Salutari, Vanda

AU - Attademo, Laura

AU - Guizzaro, Lorenzo

AU - Schettino, Clorinda

AU - Piccirillo, Maria Carmela

AU - Perrone, Francesco

AU - Gallo, Ciro

AU - Pignata, Sandro

PY - 2019

Y1 - 2019

N2 - Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.

AB - Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.

KW - Chemotherapy-induced neutropenia

KW - Cytotoxic dosing methods

KW - Meta-analysis

KW - Obstetrics and Gynecology

KW - Oncology

KW - Ovarian cancer

KW - Prognostic factors

KW - Retrospective-prospective design

KW - Chemotherapy-induced neutropenia

KW - Cytotoxic dosing methods

KW - Meta-analysis

KW - Obstetrics and Gynecology

KW - Oncology

KW - Ovarian cancer

KW - Prognostic factors

KW - Retrospective-prospective design

UR - http://hdl.handle.net/10807/135449

UR - http://www.elsevier.com/inca/publications/store/6/2/2/8/4/0/index.htt

U2 - 10.1016/j.ygyno.2019.04.012

DO - 10.1016/j.ygyno.2019.04.012

M3 - Article

SN - 0090-8258

VL - 154

SP - 83

EP - 88

JO - Gynecologic Oncology

JF - Gynecologic Oncology

ER -

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo